Related Experiment Video
Updated: Jun 4, 2026
07:30
Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
Published on: May 10, 2018
Somatostatin and dopamine receptors
1Department of Endocrinology & Medical Sciences (DiSEM), University of Genoa, Genoa, Italy.
Tumori
|February 10, 2011
Summary
New somatostatin analogs targeting somatostatin receptors (SSRs) and dopamine receptors (DRs) offer novel treatments for resistant pituitary and neuroendocrine tumors. Understanding receptor interactions is key for effective patient selection and therapy.
Area of Science:
- Endocrinology
- Molecular Biology
- Oncology
Background:
- Somatostatin receptors (SSRs) and dopamine receptors (DRs) play crucial roles in pituitary and neuroendocrine tumor (NET) development.
- Existing therapies using conventional analogs show limitations in treating resistant tumors.
Purpose of the Study:
- To explore the therapeutic potential of novel somatostatin analogs and hybrid molecules targeting SSRs and DRs.
- To investigate the role of SSR-DR crosstalk in tumor cell signaling and growth.
- To highlight the importance of receptor profiling for personalized medicine in NET treatment.
Main Methods:
- Characterization of novel somatostatin analogs and hybrid molecules.
- Analysis of SSR and DR crosstalk at the membrane level.
- Evaluation of therapeutic efficacy in preclinical models of pituitary and neuroendocrine tumors.
Main Results:
- New analogs exhibit a broader and distinct activity spectrum compared to conventional agents.
- SSRs and DRs crosstalk influences intracellular signaling pathways controlling cell growth.
- Novel agents show promise in controlling hormone secretion and reducing tumor burden.
Conclusions:
- Novel somatostatin analogs and hybrid molecules represent a promising therapeutic avenue for resistant pituitary and neuroendocrine tumors.
- Targeting SSRs and DRs, considering their crosstalk, can offer improved treatment outcomes.
- Accurate receptor profiling is essential for patient stratification and optimizing therapeutic response.
Related Concept Videos
01:28Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:30Spare Receptors
Some receptors remain unoccupied even when an agonist produces a maximal response. Such empty ones are called spare receptors. In presence of spare receptors the maximum effect of an agonist drug is achieved with fewer than 100% of the receptors being occupied. To determine the presence of spare receptors, scientists often compare the concentration of the drug needed to produce 50% of the maximum effect (EC50) with the concentration of the drug needed to occupy 50% of the receptors (Kd). If the...
01:22Opioid Receptors: Overview
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
01:30Regulation of Food Intake
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...